What is xerosis
dry skin
Xerosis treatment
Emollients
* first line for ___
* restores barrier and skin ___
itching
function
Agents to reduce itching
menthol and camphor
* ___ sensation
pramoxine
* local ___
aluminum acetate
* alter C-fiber ___ transmission hydrocortisone
* anti- ___
Dermatitis - Inflammatory process of the upper
___ layers of skin
2
acute dermatitis
sub-acute dermatitis
chronic dermatitis
stasis
Acute Contact Dermatitis
Irritant - non ___ reaction to frequent contact with everyday substances
* more common than allergic
* reaction within a few ___
Contact Dermatitis - Poison Ivy
T or F: poison ivy does not spread from lesions
True
Contact Dermatitis - Poison Ivy
* ___ is key
* Ivy-Block - reapply every ___ hours
* topical therapy OK if less than ___ % BSA involved
* Treat with: ___ lotion, topical or oral antihistamines, topical or oral corticosteroids
T or F: corticosteroid dose packs are first line therapy for acute dermatitis
False; do not provide treatment for long enough
Treatment of acute dermatitis
prednisone ___ mg per day; taper every ___ days
* minimum of ___ days of treatment
Atopic Triad
atopic dermatitis
Pruritis
symmetrical red papules or plaques
Topical Corticosteroids
Classified according to potency which corresponds to ___ activity and ___ potency
* only ___ % absored when applied to normal intact skin
* vehicle impacts delivery and ___ of corticosteroids
Side effects of topical corticosteroids
* ___ of skin
* ___ blood vessels
* ___ bruising
* skin ___ changes
* development of ___ (tachyphylaxis)
* risk of ___ suppression with long term use of high potency agents
Topical Corticosteroids
very high potency class 1
* betamethasone dipropionate ___
* halobetasol proprionate
* clobetasone proprionate
* do not use on ___
* do not use longer than ___ weeks
* no more than ___ grams per week
Topical Corticosteroids
high potency class 2
* betamethasone dipropionate ___
* fluocinolide
* same comments as very high potency class 1
cream
Topical Corticosteroids
mid potency classes 3-5
* triancinolone acentonide
* mometasone furoate
* betamethasone dipropionate ___
* used on mores skin surfaced for exacerbations
* moderate ___ effect
* safer for ___ term useage
* dont use long term on ___
Topical Corticosteroids
low potency calsses 6-7
* ___
* desonide
* can use on ___ , groin, ___ , axilla
* mild ___ effect
* safest for ___ term use
Topical Calcineurin Inhibitors
Crisaborole 2% Ointment
Dupilumab
Dupixent
* MOA: Human monoclonal antibody against ___ receptor alpha. Inhibits ___ and ___ signalling
* administered ___ every ___ weeks
* first biologic indicated for mod-severe AD for ages ___ +
Upadacitinib
Rinvoq
* moderate to severe AD
* MOA: ___ inhibitor
* Mediates signaling of cytokines and ___
* higher rates of major __ events and ___